There is no single guaranteed figure for how much weight you can lose on Mounjaro (tirzepatide) in 3 months, because the first weeks are spent on low starter doses and results vary from person to person. As a realistic guide, many people lose a modest but meaningful percentage of their body weight in the first three months, with the pace usually increasing as the dose steps up over time. Individual results vary; not everyone reaches this.
What does the trial evidence actually show?
The headline figure for Mounjaro comes from a 72-week trial, not a 3-month one, so it cannot be applied directly to three months. In the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
That 22.5% was achieved over roughly 16 months on the highest licensed dose of 15mg, reached gradually through a step-by-step titration. In your first 3 months you will still be working up through the lower doses, so it is unrealistic to expect a proportion of that figure in such a short window.
Why is the first 3 months slower than later months?
The first 3 months on Mounjaro are usually slower because the dose is deliberately started low and increased gradually to help your body adjust and reduce side effects. Mounjaro (tirzepatide) activates two gut-hormone receptors — GLP-1 and GIP — which reduce appetite and slow how quickly the stomach empties, and the full effect builds as the dose rises.
The licensed titration begins at a 2.5mg starter dose, then steps up to 5mg, 7.5mg, 10mg and 12.5mg before reaching the 15mg maximum. Each step is a weekly self-injection, and your prescriber decides when to increase based on how you are tolerating the medicine. In a typical three-month period you may only reach around the 5mg to 10mg range, which is why early loss tends to be gradual rather than dramatic.
What is a realistic monthly pattern in the first 3 months?
A realistic pattern in the first 3 months on Mounjaro is a gradual, generally accelerating loss as your dose increases, rather than a fixed amount each week. Weight does not come off in a straight line — some weeks show more movement than others, and short plateaus are normal even when the medicine is working.
- Month 1 (starter dose): often the smallest loss, as the 2.5mg starter dose is primarily about tolerance, not maximum effect.
- Month 2 (first step-ups): appetite reduction usually becomes more noticeable as the dose increases.
- Month 3 (higher dose, if tolerated): many people find the pace of loss picks up as the dose climbs.
Health professionals generally regard a loss of around 5% of body weight by about three to four months as a reasonable early sign that treatment is helping — but this is a guide, not a promise, and your prescriber will review your individual progress.
What affects how much you lose on Mounjaro?
How much you lose on Mounjaro depends on a combination of the dose you reach, how your body responds, and what you do alongside the medicine. The trial results were all achieved "alongside lifestyle support", which matters: Mounjaro reduces appetite, but your food choices, protein intake, activity and sleep still shape the outcome.
- Dose reached: higher tolerated doses tend to produce greater appetite suppression.
- Starting weight and body composition: these influence the percentage lost.
- Diet and activity: protein, fibre and resistance exercise help protect muscle while you lose fat.
- Consistency: taking your weekly dose on schedule keeps levels steady.
- Individual biology: people respond differently to the same dose, which is why results vary.
How does Mounjaro compare with the other options?
Mounjaro is one of several prescription weight-management medicines, and the best choice is a clinical decision, not a league table. The table below summarises the licensed options we dispense and their published trial figures — note these come from different trials over different timeframes and are not head-to-head comparisons.
| Medicine | How taken | Published trial figure (longer-term) |
|---|---|---|
| Mounjaro (tirzepatide) | Weekly injection | 22.5% over 72 weeks (15mg, SURMOUNT-1) |
| Wegovy injection (semaglutide) | Weekly injection | 20.7% over 72 weeks (7.2mg, STEP UP) |
| Wegovy Tablet (oral semaglutide) | Daily tablet | 16.6% over 64 weeks (25mg, OASIS 4) |
| Foundayo (orforglipron) | Daily tablet | 12.4% over 72 weeks (36mg trial dose, ATTAIN-1) |
In every case: individual results vary; not everyone reaches this. You can see the full list on our treatments page or compare the weight-loss injections directly.
What side effects might affect your first 3 months?
Side effects are most common early in treatment and when the dose increases, which is one reason the titration is gradual. The common side effects of Mounjaro (affecting more than 1 in 10 people) are nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue, and these often ease as your body adjusts.
Rare but serious effects include severe allergic reaction, acute pancreatitis, severe hypoglycaemia, severe gastrointestinal disease and worsening diabetic retinopathy. If you experience severe or persistent symptoms, seek medical advice. You can report any suspected side effect through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
Who can be prescribed Mounjaro in the UK?
Mounjaro is a prescription-only medicine in the UK and is prescribed only after a clinical consultation with a GPhC-registered prescriber who confirms it is clinically appropriate for you. It is not suitable for everyone, and a prescription is never guaranteed.
The general eligibility criteria are:
- Aged 18 or over.
- A BMI of 30 or more (obesity), or a BMI of 27 to 30 with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
Mounjaro is not suitable if you are pregnant, planning pregnancy or breastfeeding; have type 1 diabetes; have a personal or family history of medullary thyroid carcinoma or MEN2; have a history of pancreatitis; have severe gastrointestinal disease, an active eating disorder, severe liver or kidney impairment, or a known allergy to the active ingredient. You can check your eligibility with a free online consultation.
How The Weight Clinic prescribes and supplies Mounjaro
The Weight Clinic is a fully regulated UK online service, and medicines are dispensed by our own GPhC-registered pharmacy (North Harrow Pharmacy, GPhC registration number 1034996). You can confirm this on the General Pharmaceutical Council's online register at pharmacyregulation.org.
The process is: (1) a free online consultation about your health and weight; (2) a registered independent prescriber reviews your answers; (3) a short video consultation where clinically needed; and (4) if suitable, the medicine is dispensed and sent by tracked delivery, with ongoing prescriber support. You can read more about us or get in touch with any questions.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
